---
$id: https://graph.org.ai/products/commodity/51201539
$type: Product
source: UNSPSC
code: "51201539"
title: "Efalizumab"
class: "51201500"
classTitle: "Immunosuppressants"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Efalizumab

**UNSPSC Code**: 51201539
**Class**: [Immunosuppressants](Immunosuppressants.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunomodulator, an immunosuppressant, and monoclonal antibody, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XX2MN88N5D. Most nations schedule Efalizumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, EFALIZUMAB remains the US FDA Preferred Term for this commodity. . Efalizumab bears US NLM identifiers UMLS ID C1320125 and NCI Concept Code C68831.

